Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes

被引：0
|
作者：
Hundal, Ripu S.
Kowalyk, Stephan
Cases, Jane
Al-Karadsheh, Amer
Wakim, Amanda P.
Doyle, Melissa
Sink, John H., II
Spence, Adrienne
Brewer, Jamie L.
Nikkel, Carla C.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-989-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy
    Shimoda, Seiya
    Okubo, Mina
    Koga, Kotaro
    Sekigami, Taiji
    Kawashima, Junji
    Kukidome, Daisuke
    Igata, Motoyuki
    Ishii, Norio
    Shimakawa, Akiko
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Furukawa, Noboru
    Nishida, Kenro
    Araki, Eiichi
    ENDOCRINE JOURNAL, 2015, 62 (02) : 209 - 216
  • [22] Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody
    Hidekatsu Yanai
    Taro Yoshimi
    Hidetaka Hamasaki
    International Journal of Diabetes in Developing Countries, 2011, 31 : 240 - 240
  • [23] Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody
    Yanai, Hidekatsu
    Yoshimi, Taro
    Hamasaki, Hidetaka
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2011, 31 (04) : 240 - 240
  • [24] ADAPTIVE BASAL-BOLUS ADVISOR FOR INSULIN TREATED PEOPLE WITH TYPE 2 DIABETES
    Panagiotou, M.
    Brigato, L.
    De Galan, B.
    Mougiakakou, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A90 - A91
  • [25] OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
    Galkina, G. A.
    Voropay, A. A.
    Levkovich, M. A.
    Vorobiov, S. V.
    Komkova, M. V.
    Morozova, N. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 15 - U223
  • [26] Basal-bolus insulin regimen is effective for hospitalized patients with type 2 diabetes
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (12): : 791 - 792
  • [27] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
  • [28] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    Kate van Brunt
    Bradley Curtis
    Tibor Ivanyi
    Elemer Balogh
    Corina Chalkiadaki
    Sharon MacLachlan
    David Neasham
    Mireia Raluy-Callado
    Diabetes Therapy, 2016, 7 : 793 - 807
  • [29] Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin
    van Brunt, Kate
    Curtis, Bradley
    Ivanyi, Tibor
    Balogh, Elemer
    Chalkiadaki, Corina
    MacLachlan, Sharon
    Neasham, David
    Raluy-Callado, Mireia
    DIABETES THERAPY, 2016, 7 (04) : 793 - 807
  • [30] Switching to basal-bolus insulin therapy is effective and safe in long-term type 2 diabetes patients inadequately controlled with other insulin regimens
    Vinagre, Irene
    Sanchez-Hernandez, Juan
    Luis Sanchez-Quesada, Jose
    Angel Maria, Miguel
    de Leiva, Alberto
    Peres, Antonio
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (05): : 249 - 253
12345